摘要
脑型钠利尿肽(BNP),简称脑钠钛,是由32个氨基酸组成的多肽,于1988年由日本学者从猪脑内分离纯化而来,故而得名.
出处
《疑难病杂志》
CAS
2004年第4期250-252,共3页
Chinese Journal of Difficult and Complicated Cases
参考文献23
-
1[1]Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand, 2001,171(4)395-403.
-
2[2]McCullough PA. B-type natriuretic peptides. A diagnostic breakthrough in heart failure. Minerva Cardioangiol,2003,51 (2): 121-129.
-
3[3]Magga J, Vuolteenaho O, Tokola H, et al. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Am Med, 1998,30(Suppll): 39-45.
-
4[4]Tremblay J, Desjardins R, Hum D, et al. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem,2002,203(1-2): 31-47.
-
5[5]Chen HH,Bumett JC. The natriuretic peptides in heart failure:diagnostic and therapeutic potentials. Proc Assoc Am Physicians, 1999,111 (5): 406-416.
-
6[6]Maisel, Padma K, Radmila K, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001,5:367-374.
-
7[7]Tateishi J, Masutani M, Ohyanagi M, et al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol,2000,23(10) :776-780.
-
8[8]Yamaguchi H, Yoshida J, Yamamoto K, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. JACC, 2004,7: 43 ( 1 ): 55-60.
-
9[9]Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol,2001,38(7) :1934-1941.
-
10[10]Lee SC, Stevens TL, Sandberg SM, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail,2002,8(3):149-154.
同被引文献20
-
1刘鹏,靳凤琳,张斌.慢性充血性心力衰竭患者血浆脑钠素、心钠素浓度与心功能的关系[J].泰山医学院学报,2006,27(5):414-415. 被引量:2
-
2Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic,prognostic and therapeutic perspectives.Clin Physiol,2001,21(6):661-672.
-
3Wieczorek ST,Wu AH,Christonson R,et al.A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation.Am Heart J,2002,144(5):834-839.
-
4Tsutamoto T,Wada A,Maeda K,et al.Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.J Am Coll Cardiol,2001,37(5):1 228-1 233.
-
5Anand IS,Fisher LD,Chiang YT,et al.Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial(Val-HeFT).Circulation,2003,107(9):1 278-1 283.
-
6Lubien E,De Maria A,Krishnaswamy P,et al.Utility of natriureic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings.Circulation,2002,105(5):595-601.
-
7Wright SP,Doughty RN,Pearl A, et al.Plasma amino-terminal pro-BNP and accuracy of heart failure diagnosis in primary care:a randomized,controlled trial.J Am Coll Cardiol,2003,42(10):1 793-1 800.
-
8Dao Q,Krishnaswamy P,Kazanegra R,et al.Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.J Am Coll Cardiol, 2001,37(2):379-385.
-
9Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Lorsartan Intervention For Endpoint reduction in hypertention study (LIFE):a randomized trial against atenolol.Lancet,2002,359(9 311):995-1 003.
-
10Fisher C,Berry C,Blue L, et al.N-terminal pro-BNP,but not the new putative cardiac hormone relation,predicts prognosis in patients with chronic heart failure.Heart,2003,89(8):879-881.
引证文献3
-
1王联发,吴振西,尹欣,张树林,李鲁光.心力衰竭患者血浆脑钠素含量及其与左心功能关系研究[J].疑难病杂志,2005,4(6):337-339. 被引量:16
-
2谢咏梅,宝花,金花.心力衰竭患者血浆脑钠素及左室射血分数变化分析[J].内蒙古医学杂志,2012,44(11):1336-1337.
-
3施明霞.脑型钠利尿肽(BNP)在心力衰竭诊断与鉴别中的应用分析[J].现代诊断与治疗,2014,25(18):4293-4294. 被引量:1
二级引证文献17
-
1王联发,陈绍良,汪海静,吴振西,黄振平.贝那普利对充血性心力衰竭患者血浆脑钠素水平的影响[J].疑难病杂志,2007,6(4):205-207.
-
2周良,刘文清,朱红俊,龚少愚,苏伟.培哚普利对充血性心力衰竭患者血浆脑钠素水平的影响[J].交通医学,2007,21(6):651-652.
-
3苗永国,李国军,李世华,陈金良,刘志明,陈洪涛.参松养心胶囊对收缩性心力衰竭患者血浆脑钠肽的影响[J].疑难病杂志,2008,7(8):454-456. 被引量:7
-
4韩凌,苗永国,陈金良,李世华,李国军.参松养心胶囊联合卡维地洛对慢性心力衰竭患者血浆脑钠肽的影响[J].中西医结合心脑血管病杂志,2009,7(5):514-515. 被引量:1
-
5张素荣,吕风华,尹宏磊,唐军,张跃光.稳心颗粒对心力衰竭患者心功能和脑钠肽水平的影响[J].实用心脑肺血管病杂志,2009,17(9):782-783. 被引量:1
-
6苏毅,慕春言,赵倡武.贝那普利对慢性心力衰竭患者临床及血浆脑钠素水平的影响[J].中国现代药物应用,2009,3(19):12-13.
-
7周勇,田芳.丹红注射液对慢性心力衰竭患者血浆脑钠素水平及心功能的影响[J].中国初级卫生保健,2009,23(9):76-77. 被引量:4
-
8周俐.氟伐他汀对慢性心力衰竭患者血浆脑钠肽的影响[J].中国老年保健医学,2009,7(5):39-40. 被引量:1
-
9韩荣萍.阿托伐他汀钙对慢性心力衰竭患者临床及血浆脑利钠肽水平的影响[J].中国临床实用医学,2010,4(2):77-79.
-
10丁岩.瑞舒伐他汀对冠心病合并慢性心力衰竭患者临床疗效及血浆脑钠肽的影响[J].中国临床实用医学,2010,4(4):46-47. 被引量:2
-
1卢兆德,潘心海,赵其莲,符兴江,孙杰,张美霞.超声多普勒与BNP对舒张性心衰的相关性研究[J].中国超声诊断杂志,2006,7(7):524-526. 被引量:1
-
2刘希增,杨洪兰,刘华恩.脑型钠利尿肽对充血性心力衰竭疗效评价的临床意义[J].山东医药,2007,47(10):13-13. 被引量:6
-
3施明霞.脑型钠利尿肽(BNP)在心力衰竭诊断与鉴别中的应用分析[J].现代诊断与治疗,2014,25(18):4293-4294. 被引量:1
-
4柴伟利,王同成.脑型钠利尿肽在心力衰竭诊断与鉴别诊断中的意义[J].山东医药,2008,48(28):4-5. 被引量:3
-
5张英姿,刘宏,高民,刘必成.血浆脑型钠利尿肽在维持性血液透析患者左室舒张功能障碍诊断中的价值[J].现代医学,2010,38(1):36-39. 被引量:4
-
6杜伟,赵瑞平.血浆脑型钠利尿肽水平在急性心肌梗死再灌注治疗中的应用价值[J].包头医学院学报,2012,28(6):147-149. 被引量:2
-
7李海平.N端B型脑钠肽在心血管疾病中的研究进展[J].实用医技杂志,2016,23(11):1208-1209. 被引量:5
-
8杨淑英,闫宝臣,宋海宏.血浆脑钠肽在慢性心衰患者中的临床意义[J].中国误诊学杂志,2012,12(8):1824-1825. 被引量:8
-
9庞春强.重组人脑钠肽对扩张型心肌病及心肌梗死所致急性心力衰竭的疗效分析[J].中国医药指南,2016,14(31):172-173. 被引量:2
-
10陈爱中,李大玉,杨国顺.慢性心房颤动患者电复律前后血浆脑钠钛浓度变化[J].岭南心血管病杂志,2009,15(1):53-55. 被引量:2